Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000893838-07-000185
Filing Date
2007-06-13
Accepted
2007-06-13 16:04:07
Documents
2
Period of Report
2007-06-11

Document Format Files

Seq Description Document Type Size
1 frm3hoffman061207_ex.html 3  
1 frm3hoffman061207_ex.xml 3 2306
2 POWER OF ATTORNEY frm3drhoffman061207ex24.txt EX-24 3434
  Complete submission text file 0000893838-07-000185.txt   7673
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address (240)268-5300
Hoffman Freddie Ann (Reporting) CIK: 0001402395 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50590 | Film No.: 07917562